Skip to main content
Year archive

DIMERIX LIMITED — 2021 filings

All 70 regulatory filings released by DIMERIX LIMITED (DXB) in 2021, sourced directly from the official regulator.

70 Filings
2021 Period
2021 filings (70)
Filing Released Lang
Ethics Approval in Australia for Phase 3 COVID-19 Study 4 pages 354.3KB
Regulatory Filings
2021-12-22 English
Dimerix Receives Further MRFF Funding for DMX-200 4 pages 332.7KB
Regulatory Filings
2021-12-21 English
Pause in Trading 1 page 108.4KB
Regulatory Filings
2021-12-15 English
DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe 5 pages 345.8KB
Regulatory Filings
2021-12-15 English
Notification regarding unquoted securities - DXB 6 pages 27.7KB
Regulatory Filings
2021-12-05 English
Investor Presentation 19 pages 2.9MB
Regulatory Filings
2021-11-22 English
Quarterly Appendix 4C and Activities Report 9 pages 492.1KB
Regulatory Filings
2021-10-24 English
First Approvals Received for Start of Phase 3 FSGS Trial 3 pages 343.7KB
Regulatory Filings
2021-10-20 English
Phase 3 DMX-200 COVID-19 Study Expands into Australia 4 pages 356.6KB
Regulatory Filings
2021-10-14 English
Change in substantial holding 3 pages 1.4MB
Regulatory Filings
2021-10-06 English
Application for quotation of securities - DXB 6 pages 27.6KB
Regulatory Filings
2021-10-04 English
Application for quotation of securities - DXB 6 pages 27.5KB
Regulatory Filings
2021-10-04 English
Notification regarding unquoted securities - DXB 5 pages 26.3KB
Regulatory Filings
2021-10-04 English
Notification regarding unquoted securities - DXB 7 pages 29.1KB
Regulatory Filings
2021-10-04 English
Notification regarding unquoted securities - DXB 5 pages 26.4KB
Regulatory Filings
2021-10-04 English
Notification regarding unquoted securities - DXB 7 pages 29.0KB
Regulatory Filings
2021-10-04 English
Change of Director's Interest Notices - JW, HA, SP and NW 11 pages 340.7KB
Regulatory Filings
2021-10-04 English
Secondary Trading Notice Pursuant to Section 708A(5)(e) 1
Regulatory Filings
2021-10-04 English
Becoming a substantial holder 2 pages 231.1KB
Regulatory Filings
2021-10-04 English
Dimerix Closes SPP Oversubscribed 4 pages 326.1KB
Regulatory Filings
2021-09-30 English
Virtual Meeting Voting and Registration Guide 7 pages 484.4KB
Regulatory Filings
2021-09-26 English
CEO's Address to Shareholders 13 pages 1.3MB
Regulatory Filings
2021-09-26 English
AGM Presentation 18 pages 2.8MB
Regulatory Filings
2021-09-26 English
Results of Meeting 4 pages 399.3KB
Regulatory Filings
2021-09-26 English
DMX-200 CLARITY COVID-19 Study Approval in India 5 pages 359.6KB
Regulatory Filings
2021-09-23 English
Change of Director's Interest Notices - JW, HA and SP 8 pages 715.9KB
Regulatory Filings
2021-09-14 English
Change in substantial holding 2 pages 138.2KB
Regulatory Filings
2021-09-02 English
Phase 3 Study in FSGS Kidney Patients Commences 3 pages 255.0KB
Regulatory Filings
2021-08-24 English
Application for quotation of securities - DXB 6 pages 27.7KB
Regulatory Filings
2021-08-23 English
Application for quotation of securities - DXB 6 pages 27.7KB
Regulatory Filings
2021-08-23 English
Secondary Trading Notice Pursuant to Section 708A(5)(e) 1
Regulatory Filings
2021-08-23 English
SPP and Options Prospectus 52 pages 687.7KB
Regulatory Filings
2021-08-23 English
Annual General Meeting - Notice and Letter to Shareholders 5 pages 519.0KB
Regulatory Filings
2021-08-23 English
Notice of Annual General Meeting/Proxy Form 50 pages 751.4KB
Regulatory Filings
2021-08-23 English
Response to ASX Query 4 pages 312.9KB
Regulatory Filings
2021-08-18 English
Application for quotation of securities - DXB 6 pages 27.6KB
Regulatory Filings
2021-08-17 English
Secondary Trading Notice Pursuant to Section 708A(5)(e) 1
Regulatory Filings
2021-08-17 English
Successful $20m Placement to Fund Phase 3 Trials 6 pages 312.9KB
Regulatory Filings
2021-08-15 English
Proposed issue of securities - DXB 7 pages 33.8KB
Regulatory Filings
2021-08-15 English
Proposed issue of securities - DXB 8 pages 35.9KB
Regulatory Filings
2021-08-15 English
Proposed issue of securities - DXB 6 pages 29.9KB
Regulatory Filings
2021-08-15 English
Proposed issue of securities - DXB 5 pages 27.9KB
Regulatory Filings
2021-08-15 English
Preliminary Final Report 2 pages 275.3KB
Regulatory Filings
2021-08-15 English
Annual Report to Shareholders 69 pages 2.6MB
Regulatory Filings
2021-08-15 English
Appendix 4G and Corporate Governance Statement 26 pages 497.5KB
Regulatory Filings
2021-08-15 English
Investor Presentation 34 pages 4.5MB
Regulatory Filings
2021-08-15 English
Trading Halt 2 pages 373.6KB
Regulatory Filings
2021-08-11 English
DMX-200 COVID-19 Study Opens More Sites in Europe and UK 3 pages 308.2KB
Regulatory Filings
2021-08-01 English
Quarterly Appendix 4C and Activities Report 8 pages 526.0KB
Regulatory Filings
2021-07-26 English
FDA Confirms Phase 3 Study Design in FSGS Kidney Disease 3 pages 270.2KB
Regulatory Filings
2021-07-18 English
Dimerix Receives Innovation Passport and ILAP Designation 3 pages 274.6KB
Regulatory Filings
2021-06-06 English
Dimerix Confirms Phase 3 FSGS Study Design With EMA 3 pages 306.5KB
Regulatory Filings
2021-06-02 English
DMX-200 Remains Eligible for Accelerated Approval 3 pages 281.6KB
Regulatory Filings
2021-05-26 English
Investor Presentation 36 pages 5.1MB
Regulatory Filings
2021-05-24 English
Update of DMX-200 Study in COVID-19 Patients in India 3 pages 254.5KB
Regulatory Filings
2021-05-11 English
COVID-19 Study Recruits Multiple Patients in Europe 3 pages 307.7KB
Regulatory Filings
2021-04-22 English
Notification of Expired Options 2 pages 269.0KB
Regulatory Filings
2021-04-20 English
Quarterly Appendix 4C and Activities Report 8 pages 497.5KB
Regulatory Filings
2021-04-07 English
Major Shareholder Loan for $5 Million 2 pages 291.2KB
Regulatory Filings
2021-03-29 English
Investor Presentation 37 pages 5.3MB
Regulatory Filings
2021-03-28 English
Clinical Study in Patients with COVID-19 Progresses 4 pages 302.3KB
Regulatory Filings
2021-03-24 English
DMX-200 Competitive Position Further Enhanced 3 pages 254.9KB
Regulatory Filings
2021-03-23 English
Lapse of Unlisted Options 2 pages 269.2KB
Regulatory Filings
2021-03-16 English
CLARITY 2.0 Study Progresses In Patients With COVID-19 4 pages 297.4KB
Regulatory Filings
2021-03-09 English
Appendix 2A 15 pages 294.2KB
Regulatory Filings
2021-02-22 English
Secondary Trading Notice Pursuant to Section 708A(5)(e) 1
Regulatory Filings
2021-02-22 English
Appendix 4D and Interim Financial Report 25 pages 914.8KB
Regulatory Filings
2021-02-21 English
Half Year Report and Update 3 pages 295.5KB
Regulatory Filings
2021-02-21 English
Dimerix Plans for Next Study in Diabetic Kidney Disease 4 pages 418.8KB
Regulatory Filings
2021-01-27 English
Quarterly Appendix 4C and Activities Report 8 pages 499.8KB
Regulatory Filings
2021-01-21 English